Livers from p53 and INK4a/ARF double knockout animals showed up to a 50% increase in liver fibrosis markers after CCL4 treatment compared to WT animals, with little to no accumulation of senescent cells. This evidence concerns the gene CDKN2A and Hepatic fibrosis.